AHA 2020: Omecamtiv Mecarbil Fraction Improves Clinical Outcomes in Chronic Heart Failure With Low Ejection
GALACTIC-HF trial results suggest a potential novel therapeutic role for cardiac myosin activators
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.